| Target Price | $33.15 |
| Price | $37.31 |
| Deviation |
11.15%
register free of charge
|
| Number of Estimates | 6 |
|
6 Analysts have issued a price target PACS Group 2026 .
The average PACS Group target price is $33.15.
This is
11.15%
register free of charge
$42.00
12.57%
register free of charge
$18.18
51.27%
register free of charge
|
|
| A rating was issued by 11 analysts: 10 Analysts recommend PACS Group to buy, 1 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the PACS Group stock has an average upside potential 2026 of
11.15%
register free of charge
|
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Billion $ | 4.09 | 5.42 |
| 31.44% | 32.53% | |
| EBITDA Margin | 4.01% | 9.15% |
| 46.58% | 128.34% | |
| Net Margin | 1.36% | 4.41% |
| 62.41% | 223.45% |
8 Analysts have issued a sales forecast PACS Group 2025 . The average PACS Group sales estimate is
This results in the following potential growth metrics:
6 Analysts have issued an PACS Group EBITDA forecast 2025. The average PACS Group EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
7 PACS Group Analysts have issued a net profit forecast 2025. The average PACS Group net profit estimate is
This results in the following potential growth metrics and future Net Margins:
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share $ | 0.38 | 1.52 |
| 50.00% | 300.00% | |
| P/E | 24.47 | |
| EV/Sales | 1.11 |
7 Analysts have issued a PACS Group forecast for earnings per share. The average PACS Group EPS is
This results in the following potential growth metrics and future valuations:
| Analyst | Rating | Action | Date |
|---|---|---|---|
| UBS |
Locked
➜
Locked
|
Locked | Dec 18 2025 |
| JP Morgan |
Locked
➜
Locked
|
Locked | Dec 17 2025 |
| RBC Capital |
Locked
➜
Locked
|
Locked | Nov 20 2025 |
| Macquarie |
Locked
➜
Locked
|
Locked | Jan 06 2025 |
| Truist Securities |
Locked
➜
Locked
|
Locked | Jan 06 2025 |
| JP Morgan |
Locked
➜
Locked
|
Locked | Dec 17 2024 |
| Stephens & Co. |
Locked
➜
Locked
|
Locked | Nov 18 2024 |
| Analyst Rating | Date |
|---|---|
|
Locked
UBS:
Locked
➜
Locked
|
Dec 18 2025 |
|
Locked
JP Morgan:
Locked
➜
Locked
|
Dec 17 2025 |
|
Locked
RBC Capital:
Locked
➜
Locked
|
Nov 20 2025 |
|
Locked
Macquarie:
Locked
➜
Locked
|
Jan 06 2025 |
|
Locked
Truist Securities:
Locked
➜
Locked
|
Jan 06 2025 |
|
Locked
JP Morgan:
Locked
➜
Locked
|
Dec 17 2024 |
|
Locked
Stephens & Co.:
Locked
➜
Locked
|
Nov 18 2024 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


